Are you Dr. Hoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Paulo Hoff, MD is an oncologist in Houston, Texas.
Education & Training
University of Brasilia Foundation Faculty of MedicineClass of 1991, MD
Clinical Trials
- Irofulven in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 1998 Aug 01
- Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- 377 citationsBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, Josep Tabernero, Stephen Clarke
The Lancet. Oncology. 2012-12-01 - 316 citationsCarvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.Mônica Samuel Avila, Silvia Moreira Ayub-Ferreira, Mauro Rogerio de Barros Wanderley Jr., Fátima das Dores Cruz, Sara Michelly Gonçalves Brandão
Journal of the American College of Cardiology. 2018-05-22 - 101 citationsIncidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil.E. Van Cutsem, Paulo M. Hoff, Joanne L. Blum, Markus Abt, Osterwalder B
Annals of Oncology. 2002-03-01
